Global Health Limited

NSEI:MEDANTA Stock Report

Market Cap: ₹295.1b

Global Health Past Earnings Performance

Past criteria checks 3/6

Global Health has been growing earnings at an average annual rate of 38.7%, while the Healthcare industry saw earnings growing at 22.9% annually. Revenues have been growing at an average rate of 14.4% per year. Global Health's return on equity is 15.5%, and it has net margins of 14.1%.

Key information

38.7%

Earnings growth rate

37.6%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate14.4%
Return on equity15.5%
Net Margin14.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Here's Why Global Health (NSE:MEDANTA) Can Manage Its Debt Responsibly

Dec 13
Here's Why Global Health (NSE:MEDANTA) Can Manage Its Debt Responsibly

The Return Trends At Global Health (NSE:MEDANTA) Look Promising

Sep 01
The Return Trends At Global Health (NSE:MEDANTA) Look Promising

With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case

Aug 02
With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case

We Think Global Health (NSE:MEDANTA) Can Manage Its Debt With Ease

Jul 15
We Think Global Health (NSE:MEDANTA) Can Manage Its Debt With Ease

Global Health Limited's (NSE:MEDANTA) Share Price Matching Investor Opinion

May 22
Global Health Limited's (NSE:MEDANTA) Share Price Matching Investor Opinion

Global Health Limited (NSE:MEDANTA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 22
Global Health Limited (NSE:MEDANTA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Returns On Capital Are Showing Encouraging Signs At Global Health (NSE:MEDANTA)

May 04
Returns On Capital Are Showing Encouraging Signs At Global Health (NSE:MEDANTA)

Do Global Health's (NSE:MEDANTA) Earnings Warrant Your Attention?

Apr 12
Do Global Health's (NSE:MEDANTA) Earnings Warrant Your Attention?

Is Global Health (NSE:MEDANTA) A Risky Investment?

Mar 22
Is Global Health (NSE:MEDANTA) A Risky Investment?

Market Participants Recognise Global Health Limited's (NSE:MEDANTA) Earnings Pushing Shares 32% Higher

Feb 13
Market Participants Recognise Global Health Limited's (NSE:MEDANTA) Earnings Pushing Shares 32% Higher

There's Been No Shortage Of Growth Recently For Global Health's (NSE:MEDANTA) Returns On Capital

Jan 18
There's Been No Shortage Of Growth Recently For Global Health's (NSE:MEDANTA) Returns On Capital

With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case

Dec 26
With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case

Global Health Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Jun 01
Global Health Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Global Health Limited's (NSE:MEDANTA) Earnings Haven't Escaped The Attention Of Investors

Mar 30
Global Health Limited's (NSE:MEDANTA) Earnings Haven't Escaped The Attention Of Investors

Revenue & Expenses Breakdown

How Global Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:MEDANTA Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2434,6274,8825,7820
30 Jun 2433,5664,8254,7330
31 Mar 2432,7514,7825,4570
31 Dec 2331,6604,5195,1860
30 Sep 2330,2774,0894,8890
30 Jun 2328,4983,6943,7280
31 Mar 2327,0993,2614,2890
31 Dec 2225,1642,4261,3680
30 Jun 2223,0432,1326660
31 Mar 2221,7251,9622,9530
31 Mar 2114,5192884420
31 Mar 2015,1823635560
31 Mar 1914,7826102460
31 Mar 1813,6773297620

Quality Earnings: MEDANTA has high quality earnings.

Growing Profit Margin: MEDANTA's current net profit margins (14.1%) are higher than last year (13.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MEDANTA's earnings have grown significantly by 38.7% per year over the past 5 years.

Accelerating Growth: MEDANTA's earnings growth over the past year (19.4%) is below its 5-year average (38.7% per year).

Earnings vs Industry: MEDANTA earnings growth over the past year (19.4%) did not outperform the Healthcare industry 29.6%.


Return on Equity

High ROE: MEDANTA's Return on Equity (15.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 11:24
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Global Health Limited is covered by 20 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Himanshu BinaniAnand Rathi Shares and Stock Brokers Limited
null nullAnand Rathi Shares and Stock Brokers Limited
null nullAsian Markets Securities Private Limited